Tag: RET inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to RET inhibitor

Fidelity Special Values Plc - Total Voting Rights

Added to Collection on: 2021-08-02 09:33:45

Tags for this article:

Drugs
Chemical compounds
Health sciences
Breakthrough therapy
Orphan drugs
Tyrosine kinase receptors
Lung cancer
Medullary thyroid cancer
RET inhibitor
RET proto-oncogene
Papillary thyroid cancer
Thyroid cancer
DOW JONES INDUSTRIAL AVERAGE INDEX
Roche Group
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic ...

Added to Collection on: 2020-12-02 06:00:00

Tags for this article:

Thyroid cancer
Drugs
Chemical compounds
Health sciences
Breakthrough therapy
Orphan drugs
Tyrosine kinase receptors
Lung cancer
Medullary thyroid cancer
RET inhibitor
RET proto-oncogene
Papillary thyroid cancer
DOW JONES INDUSTRIAL AVERAGE INDEX
Roche Group
Basel
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Roche, Blueprint catch up with Lilly as Gavreto snags FDA thyroid cancer nod

Added to Collection on: 2020-12-02 16:54:40

Tags for this article:

Anatomy
Branches of biology
Thyroid cancer
Tyrosine kinase receptors
Breakthrough therapy
Orphan drugs
Medullary thyroid cancer
Endocrine system
RET proto-oncogene
RET inhibitor
Pralsetinib
Papillary thyroid cancer

Click the tags to see associated articles and topics

View Article Details
C4 Therapeutics Aims to Launch EGFR L858R Degrader Into the Clinic in 2022

Added to Collection on: 2021-05-26 17:26:15

Tags for this article:

Lung cancer
Epidermal growth factor receptor
T790M
RET inhibitor
Non-small-cell lung carcinoma
Cancer
Branches of biology
Organic compounds
Gefitinib
C4 Therapeutics

Click the tags to see associated articles and topics

View Article Details
Blueprint Medicines Q2 Revenues Increase More Than 200 Percent

Added to Collection on: 2021-07-29 17:10:45

Tags for this article:

Life Sciences
Companies
Health sciences
Breakthrough therapy
Orphan drugs
RET inhibitor
Genentech
Non-small-cell lung carcinoma
Roche
Pralsetinib

Click the tags to see associated articles and topics

View Article Details